Parasternal Intercostal Plane Catheter for Pain Control After CABG Surgery (NCT07759570) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Parasternal Intercostal Plane Catheter for Pain Control After CABG Surgery
Turkey (Türkiye)56 participantsStarted 2026-08-30
Plain-language summary
Coronary artery bypass graft (CABG) surgery performed via sternotomy (incision of the breastbone) can cause severe pain after surgery; this can slow recovery and increase the need for opioid pain relievers. This study investigates whether placing a catheter to deliver a local anesthetic to the superficial parasternal intercostal plane reduces pain following this type of heart surgery. Patients undergoing CABG via sternotomy will be randomly assigned to either the catheter-based analgesia group or the standard pain management group. The researchers will compare postoperative pain levels and analgesic medication requirements between the two groups to determine whether this technique improves postoperative pain control.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
\- Adult patients with coronary artery disease scheduled for coronary artery bypass graft surgery
Exclusion Criteria:
* Under 18 years of age
* ASA (American Society of Anesthesiologists) Class V patients
* Non-elective emergency cases
* Patient refusal to participate in the study
* Language barrier
* Patients who have previously undergone sternotomy
* History of significant psychiatric disorders
* Patients with known long-term opioid use
* Patients with potential contraindications to nerve blocks (bleeding diathesis, infection, and allergy to local anesthetics)
* Patients with an ejection fraction \<40%
* Patients with right ventricular systolic dysfunction (patients with TAPSE \<1.8 cm)
* Patients with a left atrial diameter \>4 cm
* Patients with severe valvular heart disease
* Patients undergoing concomitant valvular heart surgery
* Patients with a history of atrial flutter and/or atrial fibrillation
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Cumulative opioid consumption at 24 hours post-operatively (mg morphine equivalent).